Fraud, Counterfeits, and Unsafe Doses: NCL Sounds Alarm on Compounded GLP-1 Market
September 5, 2025: Washington, DC – On behalf of the millions of consumers who have been lulled into believing that compounded GLP-1s are safe and effective for weight loss, the National Consumers League (NCL) appreciates the Food and Drug Administration’s updated policy statement warning that these drugs can carry significant health risks and should only be taken by patients who cannot tolerate the widely available FDA-approved GLP-1 medicines.







